Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
UCB, Inc. ( UCB Japan Co. Ltd. )
ClinicalTrials.gov Identifier:
NCT01463059
First received: October 27, 2011
Last updated: March 19, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2013
  Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: March 19, 2013